Norway to provide US$115M to develop new vaccines against pandemics

Epidemics can ruin societies on a scale only matched by wars and natural disasters. They respect no borders and do not care if their subjects are rich or poor. A global effort is therefore needed to be better prepared. That is why a new international initiative; the Coalition for Epidemics Preparedness Innovations (CEPI) was launched on 18 January 2017 at the World Economic Forum in Davos, Switzerland. The purpose of CEPI is to create new vaccines for emerging infectious diseases, to make sure the world is better secured against epidemics in the future. The Norwegian Government plans to support CEPI with an initial investment of US$115m, Norwegian Prime Minister Erna Solberg announced at the launching event.

CEPI will initially work to develop vaccines against the diseases causes by the Nipah, Lassa and Mers-CoV viruses. These diseases all have known potential to become pandemics. CEPI will also work on developing methods to be able to respond quickly to previously unknown pathogens.


The initiative to create CEPI comes as a result of the Ebola outbreak, which cost more than 11.000 lives. The world reacted too slowly and the outbreak had devastating consequences. At the same time we saw that cooperation with international actors gave us the opportunity to test a new vaccine faster than ever before during the outbreak itself, said Solberg.


The Governments of Japan, Germany and India, the Gates Foundation and Wellcome Trust are together with the Government of Norway contributing with an initial investment of approximately US$460m. The secretariat of the organization will be placed in Oslo, Norway.


The press release can be found here https://www.regjeringen.no/